Bruker (BRKRP) EBITDA Margin (2016 - 2025)
Bruker's EBITDA Margin history spans 16 years, with the latest figure at 1.3% for Q4 2025.
- For Q4 2025, EBITDA Margin fell 606.0% year-over-year to 1.3%; the TTM value through Dec 2025 reached 0.13%, down 738.0%, while the annual FY2025 figure was 0.13%, 738.0% down from the prior year.
- EBITDA Margin reached 1.3% in Q4 2025 per BRKRP's latest filing, up from 6.02% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 18.49% in Q4 2022 to a low of 6.02% in Q3 2025.
- Average EBITDA Margin over 5 years is 7.69%, with a median of 7.82% recorded in 2023.
- Peak YoY movement for EBITDA Margin: soared 670bps in 2022, then tumbled -1390bps in 2025.
- A 5-year view of EBITDA Margin shows it stood at 11.79% in 2021, then skyrocketed by 57bps to 18.49% in 2022, then crashed by -35bps to 12.11% in 2023, then tumbled by -39bps to 7.36% in 2024, then plummeted by -82bps to 1.3% in 2025.
- Per Business Quant, the three most recent readings for BRKRP's EBITDA Margin are 1.3% (Q4 2025), 6.02% (Q3 2025), and 1.49% (Q2 2025).